Follow The Filings

GMAB Genmab A/s

Health Care, filed as GENMAB A/S (SPONSORED ADS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.2%
  • $1.4M

Who owns this now

Largest portfolio weights among holders, up to 0.2% (David Witzke, Avidity Partners Management). Not free-float ownership.

  1. David Witzke 0.22%

Who owns GMAB

Sorted by value, long equity only, as of 2026 Q2.

History
David Witzke, Avidity Partners Management 0.22% Hold 50,000 $1.4M History

Weight bar: held both quarters added sold at this quarter’s reported price

Congress

2 members of Congress traded GMAB in the last three years: 3 buys and 2 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 30 filed Jul 21
  2. Josh Gottheimer D-NJ-5Joint Buy $1K–$15K Jan 16, 2025 filed Feb 10, 2025
  3. Josh Gottheimer D-NJ-5Joint Sell $1K–$15K Dec 16, 2024 filed Jan 14, 2025
  4. Josh Gottheimer D-NJ-5Joint Buy $1K–$15K Jul 19, 2024 filed Aug 15, 2024
  5. Josh Gottheimer D-NJ-5Joint Sell $1K–$15K Jun 18, 2024 filed Jul 9, 2024

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K
6-K
SCHEDULE 13G —
6-K
6-K
6-K
6-K
6-K
6-K
6-K
SCHEDULE 13G/A —
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
SCHEDULE 13G/A —
6-K
6-K

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.